COBALT CARBONYL
ICSC: 0976 |
Dicobalt octacarbonyl Cobalt tetracarbonyl Octacarbonyldicobalt C8O8Co2 / (OC)3Co(CO)2Co(CO)3 Molecular mass: 341.9 ICSC # 0976 | CAS # 10210-68-1 RTECS # GG0300000 UN # 3281 April 21, 2004 Validated |
TYPES OF HAZARD/ EXPOSURE | ACUTE HAZARDS/ SYMPTOMS | PREVENTION | FIRST AID/ |
FIRE | Combustible. Gives off irritating or toxic fumes (or gases) in a fire. | NO open flames. NO contact with oxidants. | Powder, water spray, foam, carbon dioxide. |
EXPLOSION | |||
EXPOSURE | PREVENT DISPERSION OF DUST! STRICT HYGIENE! | ||
INHALATION | Cough. Sore throat. Shortness of breath. Laboured breathing. Symptoms may be delayed (see Notes). | Local exhaust or breathing protection. | Fresh air, rest. Half-upright position. Artificial respiration may be needed. Refer for medical attention. |
SKIN | Redness. Pain. | Protective gloves. | Remove contaminated clothes. Rinse skin with plenty of water or shower. |
EYES | Pain. Redness. | Safety goggles, or eye protection in combination with breathing protection if powder. | First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then take to a doctor. |
INGESTION | Abdominal pain. Burning sensation in the throat and chest. Nausea. | Do not eat, drink, or smoke during work. | Rinse mouth. Give plenty of water to drink. Refer for medical attention. |
SPILLAGE DISPOSAL | STORAGE | PACKAGING & LABELLING | ||
Sweep spilled substance into sealable containers; if appropriate, moisten first to prevent dusting. Then remove to safe place. Personal protection: self-contained breathing apparatus. | Separated from strong oxidants. Well closed. Keep in a well-ventilated room. | Airtight. Unbreakable packaging; put breakable packaging into closed unbreakable container. Do not transport with food and feedstuffs. UN Hazard Class: 6.1 UN Packing Group: II | ||
|
COBALT CARBONYL | ICSC: 0976 |
I |
| |||
PHYSICAL |
| |||
ENVIRONMENTAL | ||||
N O T E S | ||||
Do NOT take working clothes home. The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation is therefore essential. Immediate administration of an appropriate inhalation therapy by a doctor or a person authorized by him/her, should be considered. Environmental effects from the substance have not been investigated.
|
ADDITIONAL INFORMATION | |||||
|
IMPORTANT LEGAL NOTICE: | Neither NIOSH, the CEC or the IPCS nor any person acting on behalf of NIOSH, the CEC or the IPCS is responsible for the use which might be made of this information. This card contains the collective views of the IPCS Peer Review Committee and may not reflect in all cases all the detailed requirements included in national legislation on the subject. The user should verify compliance of the cards with the relevant legislation in the country of use. The only modifications made to produce the U.S. version is inclusion of the OSHA PELs, NIOSH RELs and NIOSH IDLH values. |
- Page last reviewed: July 22, 2015
- Page last updated: July 1, 2014
- Content source: